Sale disclosed
Renee D. Gala
President & CEO
Ordinary Shares
- Reported value
- $472.8K
- Reported price
- $236.40 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Jazz Pharmaceuticals plc
Last 30 daysNo qualifying insider buying. Sales: $2.63M by 3 insiders.
Showing the first 6 of 20 trades on this page.
President & CEO
Ordinary Shares
Director
Ordinary Shares
EVP & Chief Legal Officer
Ordinary Shares
President & CEO
Ordinary Shares
Director
Ordinary Shares
EVP, Global Head of R&D & CMO
Ordinary Shares
EVP, Global Head of R&D & CMO
Ordinary Shares
EVP, Global Head of R&D & CMO
Ordinary Shares
EVP, Global Head of R&D & CMO
Ordinary Shares
EVP, Global Head of R&D & CMO
Ordinary Shares
EVP, Global Head of R&D & CMO
Ordinary Shares
Director
Ordinary Shares
Director
Ordinary Shares
Director
Ordinary Shares
EVP & Chief Legal Officer
Ordinary Shares
Director
Ordinary Shares
EVP & Chief Legal Officer
Ordinary Shares
EVP, Chief Commercial Officer
Ordinary Shares
Director
Ordinary Shares
Director
Ordinary Shares
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| President & CEO | Ordinary SharesSale10b5-1 | 2,000$236.40 / share | $472.8K | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Director | Ordinary SharesSale10b5-1 | 6,000$230.33 / share | $1.38M | Oct 1Filed Oct 5 · 4d later | SEC filing |
| EVP & Chief Legal Officer | Ordinary SharesSale10b5-1 | 1,200$240.94 / share | $289.13K | Sep 10Filed Sep 14 · 4d later | SEC filing |
| President & CEO | Ordinary SharesSale10b5-1 | 2,000$243.03 / share | $486.06K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| Director | Ordinary SharesSale10b5-1 | 6,000$250.13 / share | $1.5M | Sep 1Filed Sep 2 · 1d later | SEC filing |
| EVP, Global Head of R&D & CMO | Ordinary SharesSale10b5-16 trades | 76,921avg $249.70 / share | $19.21M | Aug 27Filed Aug 31 · 4d later | 6 filings
|
| Director | Ordinary SharesSale10b5-1 | 6,000$252.98 / share | $1.52M | Aug 3Filed Aug 5 · 2d later | SEC filing |
| Director | Ordinary SharesSale10b5-1 | 6,000$240.47 / share | $1.44M | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Ordinary SharesSale10b5-1 | 1,157$230.55 / share | $266.75K | Jun 15Filed Jun 17 · 2d later | SEC filing |
| EVP & Chief Legal Officer | Ordinary SharesSale10b5-1 | 1,200$231.83 / share | $278.2K | Jun 10Filed Jun 12 · 2d later | SEC filing |
| Director | Ordinary SharesSale10b5-1 | 6,000$235.12 / share | $1.41M | Jun 1Filed Jun 3 · 2d later | SEC filing |
| EVP & Chief Legal Officer | Ordinary SharesSale10b5-1 | 1,192$236.97 / share | $282.47K | May 28Filed Jun 1 · 4d later | SEC filing |
| EVP, Chief Commercial Officer | Ordinary SharesSale | 6,907$235.41 / share | $1.63M | May 28Filed Jun 1 · 4d later | SEC filing |
| Director | Ordinary SharesSale | 2,741$241.57 / share | $662.14K | May 22Filed May 27 · 5d later | SEC filing |
| Director | Ordinary SharesSale | 2,000$241.00 / share | $482K | May 22Filed May 27 · 5d later | SEC filing |
Showing the latest 20 of 24 trades. Show all 24 trades
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.